These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 24481770)

  • 1. No increase in blood transfusions during liver transplantation since the withdrawal of aprotinin.
    Schofield N; Sugavanam A; Thompson K; Mallett SV
    Liver Transpl; 2014 May; 20(5):584-90. PubMed ID: 24481770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prophylactic use of tranexamic acid and aprotinin in orthotopic liver transplantation: a comparative study.
    Dalmau A; Sabaté A; Koo M; Bartolomé C; Rafecas A; Figueras J; Jaurrieta E
    Liver Transpl; 2004 Feb; 10(2):279-84. PubMed ID: 14762867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of aprotinin and tranexamic acid on blood loss and red blood cell transfusion requirements during the late stages of liver transplantation.
    Ickx BE; van der Linden PJ; Melot C; Wijns W; de Pauw L; Vandestadt J; Hut F; Pradier O
    Transfusion; 2006 Apr; 46(4):595-605. PubMed ID: 16584436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detrimental effect of aprotinin ban on amount of blood loss during liver transplantation: single-center experience.
    Trzebicki J; Kosieradzki M; Flakiewicz E; Kuzminska G; Wasiak D; Pacholczyk M; Lagiewska B; Lisik W; Kosson D; Kulik A; Chmura A; Lazowski T
    Transplant Proc; 2011 Jun; 43(5):1725-7. PubMed ID: 21693266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemostasis and blood requirements in orthotopic liver transplantation with and without high-dose aprotinin.
    Llamas P; Cabrera R; Gómez-Arnau J; Fernández MN
    Haematologica; 1998 Apr; 83(4):338-46. PubMed ID: 9592984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery.
    Karkouti K; Beattie WS; Dattilo KM; McCluskey SA; Ghannam M; Hamdy A; Wijeysundera DN; Fedorko L; Yau TM
    Transfusion; 2006 Mar; 46(3):327-38. PubMed ID: 16533273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of thromboelastometry in the assessment of hemostasis during orthotopic liver transplantation reduces the demand for blood products.
    Trzebicki J; Flakiewicz E; Kosieradzki M; Blaszczyk B; Kołacz M; Jureczko L; Pacholczyk M; Chmura A; Lagiewska B; Lisik W; Wasiak D; Kosson D; Kwiatkowski A; Lazowski T
    Ann Transplant; 2010; 15(3):19-24. PubMed ID: 20877262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions.
    Casati V; Guzzon D; Oppizzi M; Bellotti F; Franco A; Gerli C; Cossolini M; Torri G; Calori G; Benussi S; Alfieri O
    J Thorac Cardiovasc Surg; 2000 Sep; 120(3):520-7. PubMed ID: 10962414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prophylactic effect of aprotinin on intraoperative bleeding in liver transplantation: a randomized clinical study.
    García-Huete L; Domenech P; Sabaté A; Martínez-Brotons F; Jaurrieta E; Figueras J
    Hepatology; 1997 Nov; 26(5):1143-8. PubMed ID: 9362354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aprotinin efficacy on intraoperative bleeding and transfusion requirements in orthotopic liver transplantation.
    Patrassi GM; Viero M; Sartori MT; De Silvestro G; Rossaro L; Burra P; Nolli ML; Piccinni P; Bassi N
    Transfusion; 1994 Jun; 34(6):507-11. PubMed ID: 7517586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Removal of aprotinin from low-dose aprotinin/tranexamic acid antifibrinolytic therapy increases transfusion requirements in cardiothoracic surgery.
    Vonk AB; Meesters MI; Schats J; Romijn JW; Jansen EK; Boer C
    Interact Cardiovasc Thorac Surg; 2011 Feb; 12(2):135-9. PubMed ID: 21075830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reduction of the need for blood derivatives in liver transplantation using aprotinin].
    Monedero P; Páramo JA; Carrascosa F; Herrero JI; Hidalgo F; Iribarren MJ; García-Pedrajas F
    Rev Esp Anestesiol Reanim; 1995 Mar; 42(3):82-6. PubMed ID: 7539932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of aprotinin in orthotopic liver transplantation: can its harmful effects offset its beneficial effects?
    Lentschener C; Roche K; Ozier Y
    Anesth Analg; 2005 May; 100(5):1248-1255. PubMed ID: 15845662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of tranexamic acid vs. aprotinin on blood loss and transfusion requirements after cardiopulmonary bypass: a prospective, randomised, double-blind trial.
    Hekmat K; Zimmermann T; Kampe S; Kasper SM; Weber HJ; Geissler HJ; Mehlhorn U
    Curr Med Res Opin; 2004 Jan; 20(1):121-6. PubMed ID: 14741082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of aprotinin in cardiac surgery: effectiveness and safety in a population-based study.
    Jakobsen CJ; Søndergaard F; Hjortdal VE; Johnsen SP
    Eur J Cardiothorac Surg; 2009 Nov; 36(5):863-8. PubMed ID: 19782573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aprotinin reduces red blood cell transfusion in orthotopic liver transplantation: a prospective, randomized, double-blind study.
    Findlay JY; Rettke SR; Ereth MH; Plevak DJ; Krom RA; Kufner RP
    Liver Transpl; 2001 Sep; 7(9):802-7. PubMed ID: 11552215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinolytic inhibitors in off-pump coronary surgery: a prospective, randomized, double-blind TAP study (tranexamic acid, aprotinin, placebo).
    Vanek T; Jares M; Fajt R; Straka Z; Jirasek K; Kolesar M; Brucek P; Maly M
    Eur J Cardiothorac Surg; 2005 Oct; 28(4):563-8. PubMed ID: 16125959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study. EMSALT Study Group.
    Porte RJ; Molenaar IQ; Begliomini B; Groenland TH; Januszkiewicz A; Lindgren L; Palareti G; Hermans J; Terpstra OT
    Lancet; 2000 Apr; 355(9212):1303-9. PubMed ID: 10776742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination?
    Bulutcu FS; Ozbek U; Polat B; Yalçin Y; Karaci AR; Bayindir O
    Paediatr Anaesth; 2005 Jan; 15(1):41-6. PubMed ID: 15649162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.